A Multi-Centre Open-Label Randomized Phase II Study of Osimertinib with and without Ramucirumab in TKI-naive EGFR-mutant Metastatic NSCLC (RAMOSE trial interim analysis)
Osimertinib;Ramucirumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Multi-Centre Open-Label Randomized Phase II Study of Osimertinib with and without Ramucirumab in TKI-naive EGFR-mutant Metastatic NSCLC (RAMOSE trial interim analysis) ### Output: Osimertinib;Ramucirumab